Frontlight ResearchEarly access
CompletedNo phase
Nutritional Treatment for the Amelioration of Traumatic Brain Injury
Key facts
- Who runs it
- Queen Mary University of London
- Where
- United Kingdom1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 32 people enrolled
- Started
- 14 Oct 2021
- Ended
- 30 Apr 2024
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Souvenaid oral nutritional supplement (Nutricia)
- Record updated
- 29 November 2024
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Adult between 18 yrs and 80 yrs of age
- Acute traumatic brain injury with confirmed radiological features
Who cannot take part
- Concurrent active neurological disease
- Allergies to fish oil/milk/soya
- Medical history of galactosaemia
- Non-traumatic aetiology to head injury
- Unable to receive enteral nutrition
- Craniectomy during admission (loss of integrity of skull convexity)
- Pregnancy or breastfeeding
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
To test the feasibility of administering a commercially available neurotrophic oral nutritional supplement (ONS) for adult patients with acute traumatic brain injury at the Royal London Hospital.
The 2 groups in the trial
- ControlNo study treatment, for comparison
Routine NHS care following traumatic brain injury
- TreatmentTreatment being tested
Routine NHS care following traumatic brain injury plus daily dose of test compound (oral nutritional supplement)
Treatment: Souvenaid oral nutritional supplement (Nutricia)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 29 November 2024